Quantcast
Russia's RDIF expects EMA approval of Sputnik V COVID-19 vaccine within two months -Ifax - Metro US

Russia’s RDIF expects EMA approval of Sputnik V COVID-19 vaccine within two months -Ifax

FILE PHOTO: Doses of the Sputnik V vaccine against the coronavirus disease (COVID-19) are seen at a vaccination centre

MOSCOW (Reuters) – Russia’s RDIF sovereign wealth fund expects to receive approval for the Sputnik V vaccine against COVID-19 from the European Medicines Agency within two months, the Interfax news agency reported on Wednesday.

Reuters reported earlier on Wednesday that European Union approval of Sputnik V will be delayed because a June 10 deadline to submit data was missed, citing two people familiar with the matter.

(Reporting by Maria Kiselyova; Writing by Alexander Marrow; editing by Louise Heavens)

More from our Sister Sites